Page results
-
Our vaccination centre at the Business Design Centre, Islington, closed on Monday 10 January.
-
Clinician researchers at UCLH and UCL are leading a major UK clinical trial to test whether proton beam therapy (PBT) can significantly improve survival for patients with mesothelioma, a rare and aggressive cancer of the lining of the lung.
-
Mixed sex accommodation and privacy information for patients coming into hospital for an inpatient stay
-
Having proton beam therapy: information for teenagers aged 13-17 patient information.
-
Having proton beam therapy: information for children aged 9-12 patient information
-
Information on how we ask for your consent to treatment, and Martha's Rule.
-
Having proton beam therapy: information for children aged 5-8 patient information page.
-
This page answers common questions asked by colorectal patients.
-
UCLH is accelerating clinical trial delivery so that patients gain access to new treatments sooner. The acceleration is happening through close collaboration between research teams and clinical services.
-
University College London Hospitals (UCLH) is now administering new COVID-19 treatments for patients at highest risk in the community.
File results
-
FOI/2023/0075 - Attrition rates for staff working in advanced practice roles
-
FOI/2023/0080 - Treatment for Myeloid leukaemia (AML) and chronic lymphocytic leukaemia
-
FOI/2023/0081 - Biometric technology wearables/ data collection
-
FOI/2023/0082 - Organisation structure for Performance and Planning department
-
FOI/2023/0083 - Software systems/ suppliers used at Trust
-
FOI/2023/0086 - Number/ wait times for MRI scans for multiple sclerosis/ dementia/ prostate/ pancreatic cancer
-
FOI/2021/0284 - Sleep respiratory service
-
FOI/2023/0099 - Number of autoclaves used at Trust
-
FOI/2023/0101 - Trauma protocols in pregnant patients
-
FOI/2023/0103 - Genetic Haemochromatosis patients